Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibrutinib + Rituximab in Previously Untreated Follicular Lymphoma
NCT01980654Phase 2Completed
- Sponsor
- Pharmacyclics
- Start
- Dec 2013
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibrutinib in follicular lymphoma (FL), sponsored by Pharmacyclics. Started Dec 2013; status: completed.
02
Drugs
ibrutinib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01980654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01980654.